in3

in3

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2017 - 31 Dec 2021
Client: 
Marie Skłodowska-Curie Action - Innovative Training Network (H2020)

ABOUT THIS PROJECT

The Marie Skłodowska-Curie Innovative Training Network in3 aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial safety assessment. State-of-the-art human induced pluripotent stem cells research, cheminformatics, mechanistic toxicology and biokinetics are integrated safety assessment approaches. DC is hosting one of the 15 PhD students working on data management and integration, harmonization of analysis workflows and biomarker identification for key events of adverse outcome pathways. Recruitment for this and other positions in the network is still ongoing.

Latest Tweets

Douglas Connect (1 hour ago)
RT @DanyX23: Finally got around to watching the recording of my first conference talk about @elmlang. I think it works quite well to introd…
Douglas Connect (1 hour ago)
Our Senior Software Developer, Daniel Bachler, at GOTO 2017 https://t.co/wZ5rYYnju2
Douglas Connect (3 days ago)
RT @eNanoMapper: survey results and outlook paper by an US-EU collaboration about the future of data integration for nanosafety, including…
Douglas Connect (3 days ago)
RT @eNanoMapper: new paper: "toxFlow: a Web-Based Application for Read-Across Toxicity Prediction using Omics and Physicochemical Data" htt…
Douglas Connect (5 days ago)
Last chance to apply for 2018 OpenTox internships (deadline Jan 15th) The goal of OpenTox is to develop an interope… https://t.co/IcIoRWQohc

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com